| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,440 |
4,626 |
$282K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,358 |
1,201 |
$104K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,084 |
1,772 |
$58K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
484 |
460 |
$34K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
369 |
348 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,906 |
1,419 |
$25K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
468 |
374 |
$24K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
853 |
707 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,771 |
1,519 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
226 |
208 |
$9K |
| 87807 |
|
723 |
601 |
$5K |
| D0145 |
Oral evaluation for a patient under three years of age |
159 |
151 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
41 |
41 |
$3K |
| D1206 |
Topical application of fluoride varnish |
147 |
136 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
510 |
415 |
$3K |
| 92551 |
|
590 |
528 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
119 |
119 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
183 |
182 |
$2K |
| 92567 |
|
231 |
184 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
70 |
37 |
$1K |
| 90670 |
|
169 |
141 |
$1K |
| 96127 |
|
331 |
305 |
$915.90 |
| 99382 |
|
15 |
13 |
$654.37 |
| 99173 |
|
562 |
500 |
$480.53 |
| 99383 |
|
24 |
14 |
$391.60 |
| 85018 |
|
260 |
235 |
$389.42 |
| 94664 |
|
38 |
31 |
$316.97 |
| 99188 |
|
788 |
671 |
$298.27 |
| 83655 |
|
25 |
25 |
$245.25 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
15 |
$120.90 |
| 90647 |
|
125 |
102 |
$70.83 |
| 81002 |
|
26 |
26 |
$70.50 |
| 99442 |
|
18 |
12 |
$56.10 |
| 97802 |
|
171 |
148 |
$24.00 |
| 90461 |
|
499 |
415 |
$21.20 |
| 96161 |
|
23 |
13 |
$14.81 |
| 94760 |
|
15 |
14 |
$3.20 |
| 96160 |
|
42 |
23 |
$1.75 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
36 |
27 |
$0.01 |
| 90723 |
|
114 |
95 |
$0.00 |
| 90680 |
|
44 |
40 |
$0.00 |
| 90686 |
|
39 |
26 |
$0.00 |
| 90677 |
|
96 |
81 |
$0.00 |
| 90648 |
|
16 |
15 |
$0.00 |
| 90633 |
|
45 |
37 |
$0.00 |